CNN, CNN Indonesia | Monday, 28/06/2021 22:45 WIB Jakarta, CNN Indonesia — AstraZeneca has started trials of a vaccine against several variants of the coronavirus. The new vaccine is designed to protect citizens from the beta variant that was first discovered in South Africa. The trial will be carried out on people who have been … Read more
Jakarta – Recent reports show AstraZeneca vaccine effective against varian Delta, Corona variant which is called very fast transmission and was first discovered in India. The efficacy of the vaccine against Kappa, another variant found in India, has also been proven. The results come from a recent Oxford University study on the ability of monoclonal … Read more
Jakarta – The emergence of a new variant of Corona in Indonesia is said to be one of the causes of cases COVID-19 recently rebounded. There are three variants that have been identified in Indonesia, namely the Alpha variant (B117), the Beta variant (B1351), and the Delta variant (B1617.2), all three of which are included … Read more
Jakarta – Companies that develop the Corona vaccine together Pfizer, BioNTech, said the vaccine he made was effective against the new Corona from India B1617. They believe this because the Corona vaccine has proven effective against the COVID-19 variant from South Africa (South Africa). “So far, we have had the opportunity to test our vaccine … Read more
Monday, 05 Apr 2021 21:29 WIB Foto Health Pool – detikHealth The ‘Eek’ variant, aka the E484K mutation, is now hotly discussed. After it was reported found in Japan, the Indonesian Ministry of Health reported 1 case finding in Indonesia. – .
Jakarta – After it had subsided, a number of countries in Asia had to face another surge until a new wave COVID-19. There are those who have to fight against the ‘king variant’ B1351 from South Africa which triggers the transmission faster. These countries have been forced to return to lockdown due to the new … Read more
Jakarta – Until now, there are more than 80 types of candidates the COVID-19 vaccine in the world that is in the clinical trial stage. WHO researchers predict that by the end of 2021 there will be another six to eight vaccine candidates ready to be analyzed for emergency use. Chief researcher WHO, Soumya Swaminathan, … Read more